Literature DB >> 1494811

Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. A case report.

A Berruti1, G Gorzegno, G Vitetta, M Tampellini, L Dogliotti.   

Abstract

Interferon-alpha might increase triglyceride serum levels through the enhancement of hepatic lipogenesis and/or inhibition of the peripheral lipoprotein lipase. Hypertriglyceridemia during interferon-alpha therapy has been only recently described, mostly in patients with previous abnormalities of lipid metabolism. The authors report here a case of a 65-year-old male bearing advanced colon carcinoma who developed hypertriglyceridemia during long-term interferon-alpha treatment in association with 5 fluorouracil administration. Hypertriglyceridemia was maintained within acceptable levels, without adjusting the treatment plan, by an appropriate diet and gemfibrosil administration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494811     DOI: 10.1177/030089169207800515

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  2 in total

1.  Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy.

Authors:  F Grubisić-Cabo; E Vrdoljak
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.